Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 30;13(6):915.
doi: 10.3390/jpm13060915.

Restless Legs Syndrome in Parkinson's Disease

Affiliations

Restless Legs Syndrome in Parkinson's Disease

Ştefania Diaconu et al. J Pers Med. .

Abstract

Background: Restless legs syndrome (RLS) might worsen sleep quality and quality of life in people with Parkinson's disease (PwPD).

Objective: The main aim of the present study is to explore the associations between RLS and sleep, quality of life and other non-motor symptoms (NMS) in a sample of PwPD.

Methods: We compared the clinical features of 131 PwPD with and without RLS, in a cross-sectional study. We used several validated scales for assessment: the International Restless Legs Syndrome Study Group rating scale (IRLS), Parkinson's Disease Sleep Scale version 2 (PDSS-2), Parkinson's Disease Questionnaire (PDQ-39), Non-Motor Symptoms Questionnaire (NMSQ) and International Parkinson and Movement Disorder Society Non-Motor Rating Scale (MDS-NMS).

Results: Thirty-five patients (26.71%) out of the total PwPD met the RLS diagnostic criteria, without significant differences between male (57.14%) and female (42.87%) (p = 0.431). Higher total scores of PDSS-2 were recorded among PwPD + RLS (p < 0.001), suggesting worse sleep quality. Significant correlations were observed between the diagnosis of RLS and some types of pain (especially nocturnal pain), physical fatigue and probable sleep-disordered breathing, according to the MDS-NMSS assessment.

Conclusions: RLS has a high frequency in PwPD and it requires proper management, considering its consequences on sleep and quality of life.

Keywords: Parkinson’s disease; fatigue; non-motor symptoms; pain; restless legs syndrome; sleep quality.

PubMed Disclaimer

Conflict of interest statement

C.F.-P. received royalties from Elsevier and Springer Verlag, honoraria from Abbvie and the International Parkinson’s Disease and Movement Disorders Society, outside of the present work. D.Ț. received honoraria from Pfizer, Boehringer Ingelheim, Bayer, Novartis, and Astra Zeneca outside of the present work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The last author is currently co-Editor of the Special Issue.

Figures

Figure 1
Figure 1
Mean scores in the dimensions of PDQ 39 between the two groups. Significant differences were marked with asterisk (*), and were seen in the dimension bodily discomfort (p < 0.001) and PDQ 39 total score (p = 0.046); Mann–Whitney U Test. PD: Parkinson’s disease; PDQ-39: Parkinson’s Disease Questionnaire; PwPD: people with Parkinson’s disease; RLS: restless legs syndrome.
Figure 2
Figure 2
Mean scores in the applied scaled between the two groups (PwPD + RLS vs. PwPD − RLS); Mann–Whitney U Test. ESS: Epworth Sleepiness Scale; ISI: Insomnia Severity Index; PD: Parkinson’s disease; PDQ-39: Parkinson’s Disease Questionnaire; PDSS-2: Parkinson Disease Sleep Scale 2; PwPD: people with Parkinson’s disease; RLS: restless legs syndrome.
Figure 3
Figure 3
Severity of PDSS-2 scores, in accordance with the severity of the IRLS scale (1 = mild; 2 = moderate; 3 = severe). IRLS: International Restless Legs Syndrome Study Group rating scale; PDSS-2: Parkinson Disease Sleep Scale-2.
Figure 4
Figure 4
Severity of the MDS-NMS total score, in accordance with the severity of the IRLS scale (1 = mild; 2 = moderate; 3 = severe). IRLS: International Restless Legs Syndrome Study Group rating scale; MDS-NMSS: International Parkinson and Movement Disorder Society Non-Motor Rating Scale; PD: Parkinson’s disease. The ° represents an outlier from the median score.

References

    1. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisi J. Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–119. doi: 10.1016/s1389-9457(03)00010-8. - DOI - PubMed
    1. Allen R.P., Picchietti D.L., Garcia-Borreguero D., Ondo W.G., Walters A.S., Winkelman J.W., Zucconi M., Ferri R., Trenkwalder C., Lee H.B. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria—History, rationale, description, and significance. Sleep Med. 2014;15:860–873. doi: 10.1016/j.sleep.2014.03.025. - DOI - PubMed
    1. Winkelmann J., Wetter T.C., Collado-Seidel V., Gasser T., Dichgans M., Yassouridis A., Trenkwalder C. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 2000;23:597–602. doi: 10.1093/sleep/23.5.1b. - DOI - PubMed
    1. Khachatryan S.G., Ferri R., Fulda S., Garcia-Borreguero D., Manconi M., Muntean M.L., Stefani A. Restless legs syndrome: Over 50 years of European contribution. J. Sleep Res. 2022;31:e13632. doi: 10.1111/jsr.13632. - DOI - PMC - PubMed
    1. Tison F., Crochard A., Léger D., Bouée S., Lainey E., El Hasnaoui A. Epidemiology of restless legs syndrome in French adults: A nationwide survey: The INSTANT Study. Neurology. 2005;65:239–246. doi: 10.1212/01.wnl.0000168910.48309.4a. - DOI - PubMed